We are live on ! Find out more
PIM

Provident Investment Management Portfolio holdings

AUM $1.01B
1-Year Est. Return 9.4%
This Fund
S&P 500
This Quarter Est. Return
+9.64%
1 Year Est. Return
+9.4%
3 Year Est. Return
+59.52%
5 Year Est. Return
+71.96%
10 Year Est. Return
+378.31%
AUM
$394M
AUM Growth
+$27.4M
Cap. Flow
-$2.53M
Cap. Flow %
-0.64%
Top 10 Hldgs %
56.2%
Holding
49
New
3
Increased
16
Reduced
15
Closed
–

Top Buys

Rank Stock Value
1
CTSH icon
Cognizant
CTSH
+$15.5M
2
AL
Air Lease Corp
AL
+$10.4M
3
RMD icon
ResMed
RMD
+$692K
4
QCOM icon
Qualcomm
QCOM
+$313K
5
ROP icon
Roper Technologies
ROP
+$273K

Top Sells

Rank Stock Value
1
BRLI
BIO-REFERENCE LABS INC-NEW-
BRLI
+$11M
2
G icon
Genpact
G
+$10.7M
3
HCC
HCC INSURANCES HOLDINGS INC
HCC
+$4.39M
4
GILD icon
Gilead Sciences
GILD
+$1.51M
5
WAT icon
Waters Corp
WAT
+$1.48M

Sector Composition

Rank Sector Weight
1 Financials 25.92%
2 Healthcare 20.42%
3 Consumer Discretionary 15.9%
4 Technology 15.33%
5 Industrials 8.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MCD icon
26
McDonald's
MCD
$196B
$1.46M 0.37%
15,000
– –
XOM icon
27
ExxonMobil
XOM
$642B
$1.39M 0.35%
13,726
-413
-3% -$38.2K
AMGN icon
28
Amgen
AMGN
$219B
$1.3M 0.33%
11,375
-2,400
-17% -$273K
IBM icon
29
IBM
IBM
$220B
$1.21M 0.31%
6,758
– –
FAST icon
30
Fastenal
FAST
$58.3B
$1.01M 0.26%
85,200
– –
MDT icon
31
Medtronic
MDT
$110B
$927K 0.24%
16,147
– –
KO icon
32
Coca-Cola
KO
$374B
$838K 0.21%
20,281
– –
CL icon
33
Colgate-Palmolive
CL
$74.1B
$778K 0.2%
11,926
+68
+0.6% +$4.35K
NTRS icon
34
Northern Trust
NTRS
$33.7B
$743K 0.19%
12,000
– –
EMR icon
35
Emerson Electric
EMR
$87.5B
$678K 0.17%
9,667
– –
COP icon
36
ConocoPhillips
COP
$142B
$483K 0.12%
6,831
-138
-2% -$9.91K
AFL icon
37
Aflac
AFL
$64.5B
$475K 0.12%
14,226
– –
ABT icon
38
Abbott
ABT
$187B
$468K 0.12%
12,210
– –
PM icon
39
Philip Morris
PM
$293B
$434K 0.11%
4,977
+63
+1% +$5.5K
BRK.B icon
40
Berkshire Hathaway Class B
BRK.B
$1.13T
$429K 0.11%
3,615
– –
JPM icon
41
JPMorgan Chase
JPM
$947B
$418K 0.11%
7,140
+47
+0.7% +$2.58K
NEOG icon
42
Neogen
NEOG
$2.46B
$386K 0.1%
22,499
-1
-0% -$17
NSC icon
43
Norfolk Southern
NSC
$76.9B
$345K 0.09%
3,717
– –
JNJ icon
44
Johnson & Johnson
JNJ
$619B
$343K 0.09%
3,747
+25
+0.7% +$2.3K
UNP icon
45
Union Pacific
UNP
$175B
$329K 0.08%
3,912
– –
ACN icon
46
Accenture
ACN
$105B
$271K 0.07%
3,300
– –
AAPL icon
47
Apple
AAPL
$4.56T
$270K 0.07%
13,496
-308
-2% -$5.82K
RMTI icon
48
Rockwell Medical
RMTI
$28.3M
$252K 0.06%
219
– –
WBA
49
DELISTED
Walgreens Boots Alliance
WBA
$207K 0.05%
+3,600
New +$209K
1
2

Similar funds

MIM
Miller Investment Management West Conshohocken, Pennsylvania $1.01B AUM 13.96% 1-Year Est. Return
CT
Coastline Trust Providence, Rhode Island $1.01B AUM 22.57% 1-Year Est. Return
TAMH
Taikang Asset Management (HK) Hong Kong $1B AUM 27.37% 1-Year Est. Return
PCMF
Private Capital Management (Florida) Naples, Florida $1B AUM 15.98% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
VFA
Voya Financial Advisors Windsor, Connecticut $1B AUM 12.91% 1-Year Est. Return
PGCM
Prescott Group Capital Management Tulsa, Oklahoma $1B AUM 51.95% 1-Year Est. Return
GA
GRS Advisors Chicago, Illinois $1.01B AUM 13.12% 1-Year Est. Return

Provident Investment Management's Q4 2013 Portfolio in Review

As of Q4 2013, Provident Investment Management held 49 positions worth $394M, up 7.5% from $367M the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Provident Investment Management's Q4 2013 filing shows 3 new, 16 increased and 15 reduced positions. Its largest new stake was Cognizant: 340,628 shares worth $17.2M. The largest sale was BIO-REFERENCE LABS INC-NEW-, an estimated $11M.

By sector, the portfolio is most concentrated in Financials at 26% of assets, down from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Provident Investment Management's largest Q4 2013 buy was Cognizant: 340,628 shares worth $17.2M.
  • Provident Investment Management added most to ResMed in Q4 2013, an estimated $692K increase.
  • Provident Investment Management's biggest Q4 2013 reduction was BIO-REFERENCE LABS INC-NEW-, cutting an estimated $11M.
  • Provident Investment Management's ten largest holdings make up 56% of its $394M portfolio in Q4 2013.
  • Provident Investment Management opened 3 new positions and closed 0 in Q4 2013.
  • Provident Investment Management's portfolio value rose 7.5% quarter-over-quarter to $394M.

Based on Provident Investment Management's 13F filing for Q4 2013, filed 12 Feb 2014.